THE MOSS REPORTS
Science should by definition be open-minded. As the celebrated
eighteenth century German poet and philosopher Goethe said, "As
soon as anyone belongs to a narrow creed in science, every unprejudiced
and true perception is gone." This week I begin a two-part
series on an important event that has recently been in the news:
the firing of a Boston University professor who has written a book
that puts forward ideas that run counter to current medical doctrine.
The very fact that doctrine and dogma exist in the world of medicine
is cause for concern. Science-based medicine should be founded on
rationality and open-mindedness, not on ideology.
Unfortunately, the tendency for ideology to supplant open-mindedness
has become pervasive in medicine. For the past thirty years I have
studied the world of cancer and its treatment and have written extensively
on the many potentially useful treatments that have been dismissed
out of hand simply because they challenged the prevailing medical
dogma.
The Moss Reports is a series
of more than two hundred detailed reports on different types of
cancer. If you or someone you love has cancer, a Moss
Report can offer not just an in-depth analysis of the
conventional treatment of that type of cancer, but also a thorough
examination of the available alternative and complementary treatments.
You can order a Moss Report
through our website: www.cancerdecisions.com
or by calling Diane at 1-800-980-1234
(814-238-3367 from outside the US).
VITAMIN D AND CANCER: A DERMATOLOGIST'S DILEMMA
Note: When you finish reading
this article you may be moved to take action. At the end of the
article I therefore suggest something you can do.
A Boston professor of dermatology has been asked to resign because
he advocates moderate exposure to sunlight. Michael F. Holick, MD,
PhD, a professor at Boston University, was asked to resign in April
from BU's Department of Dermatology because of a book he wrote,
in which he describes the importance of sunlight in boosting vitamin
D levels. He was also severely criticized for his ties to the indoor
tanning industry.
Department chair Barbara Gilchrest, MD, told the Boston Globe
that the book "is an embarrassment for this institution and
an embarrassment for him." As demanded, Holick resigned his
post, but continues to teach and to direct the medical center's
Vitamin D, Skin, and Bone Research Laboratory, without a cut in
pay.
Holick is a talented, experienced and highly respected researcher.
He is a professor of medicine and physiology, and formerly of dermatology,
at Boston University School of Medicine, and (until 2000) chief
of endocrinology, metabolism and nutrition. Since 1987 he has also
been the program director of the University's General Clinical Research
Center.
Department chair Gilchrest's disapproval of Holick stems from the
fact that his statements, superficially at least, seem to be at
odds with the medical profession's consensus on the damaging effects
of sunlight. Dermatologists have been warning the public for years
that sunlight, and specifically ultraviolet A (UVA) and ultraviolet
B (UVB), is implicated in the causation of melanoma, as well as
other less deadly forms of skin cancer.
But the causes of melanoma are still far from established, and
there remain many unanswered questions about the exact relationship
of sunlight exposure to the development of skin cancers. Exactly
how much ultraviolet light constitutes a safe level of exposure
is a legitimate topic for scientific debate. For example, according
to the American Cancer Society, "We do not yet know exactly
what causes melanoma …but we do know that certain risk factors
are linked to the disease….Some risk factors, such as smoking,
can be controlled. Others, like a person's age or family history,
can't be changed. But having a risk factor, or even several, doesn't
mean that a person will get the disease" (ACS 2004).
As to sunlight, the ACS says this: "The best way to lower
the risk of melanoma is to avoid too much exposure to the sun and
other sources of UV light…. Avoid being outdoors in sunlight
too long, especially in the middle of the day when UV light is most
intense…."
But this view is not universally held. William B. Grant, Ph.D.,
who heads the Sunlight, Nutrition and Health Research Center
(SUNARC) in San Francisco strongly disputes it. "This
is not particularly good advice," he told this newsletter.
"There are several papers indicating that occupational exposure
to sunlight reduces the risk of melanoma (Kennedy 2003). "It
is having fair skin, a high-fat, low fruit and vegetable diet, sunburning,
etc., that are more linked to melanoma than total UV exposure."
Reasonable people can certainly differ over this complex question.
Such vague terms as "too long" or "too much exposure"
leave much room for disagreement. In science, intellectual rigidity
is never warranted, especially when it rests on fundamental confusion
about the actual causes of a potentially fatal human disease.
Despite scientific uncertainty, the attack on Dr. Holick has taken
on a quasi-moralistic tone. Some dermatologists, possibly frustrated
at the failure of most of their treatments to reverse advanced melanoma,
now regard sun exposure without sunblock as analogous to promiscuous
sex without condoms. But ultraviolet sunlight (particularly UVB)
is not always and absolutely bad for our health. It has essential
functions, too. In particular, it enables our skin to manufacture
vitamin D: without sufficient exposure to sunlight we run the risk
of developing the deficiency disease rickets.
Vitamin D and Internal Cancers
The benefits of sunlight and vitamin D for the development of healthy
bones have long been known: a Nobel Prize was awarded for discoveries
relating to the importance of vitamin D as early as 1928.
But what has only fairly recently been discovered is
that, in addition to its role in bone metabolism, vitamin D may also help
prevent a variety of cancers. I wrote about this in my book Cancer Therapy
I quoted the work of San Diego scientists Drs. Cedric and Frank Garland, who
argued that colon cancer could be prevented by sunlight. The
Garlands went further, however, showing that "brief, regular
exposure to sunlight was probably beneficial in preventing melanoma,
while either too little or too much exposure was potentially harmful"
(Moss 1992, citing Garland 1990).
The research on the subject of vitamin D and cancer is now voluminous,
with over 3,500 PubMed articles on the topic. The US National
Institutes of Health has stated that "laboratory, animal, and
epidemiologic evidence suggest that vitamin D may be protective
against some cancers. Some dietary surveys have associated increased
intake of dairy foods with decreased incidence of colon cancer.
Another dietary survey associated a higher calcium and vitamin D
intake with a lower incidence of colon cancer" (NIH 2004).
One randomized trial, published last December, showed that people
who had high vitamin D levels benefitted from calcium supplementation:
the incidence of premalignant adenomas of the colon was reduced
by 29 percent in those who had optimal amounts of both nutrients
(Grau 2003).
Vitamin D (and indirectly, therefore, sunlight) might also convey
protection against prostate cancer. It is certainly true that more
full-scale clinical trials need to be done to test this hypothesis.
(PubMed lists 29 such trial articles.) But people are exposed to
sunlight every time they step outdoors; the public needs and deserves
preliminary recommendations from those with the greatest knowledge.
Dr. Holick's "crime" is that he has provided
an answer that is at variance with the positions of the professional
dermatology associations. Yet he is well positioned to offer an
opinion, as he himself is in the forefront of this research. He
is the author of over 200 PubMed articles on the topic of vitamin
D, the first of which appeared in 1970. The latest, published this
March, suggests the scope and importance of his research: "Vitamin
D: importance in the prevention of cancers, type 1 diabetes, heart
disease, and osteoporosis" (Holick 2004). By contrast, Dr.
Gilchrest, although herself well published in dermatology, has only
authored two PubMed papers on vitamin D, one of which she co-authored
with Dr. Holick.
It is hard to believe that a policy dispute of this sort would
warrant such a gross violation of academic freedom and intellectual
rights. We do indeed live in parlous times when doctors are removed
from high positions for offering carefully reasoned and well intended
advice to the general public on preventing cancer!
Mysteries of Sunlight
There is much about sunlight's biological effects that is not known
and no one would argue that the case for increasing ultraviolet
exposure has yet been conclusively proved. But neither is it firmly
established that blocking sunlight is entirely beneficial. In fact,
the value of physical or chemical sunscreens is itself in dispute.
In February 1998, an epidemiologist at Memorial Sloan-Kettering
Cancer Center in New York, Dr. Marianne Berwick, presented a careful
analysis of sunscreen use and skin cancer at the annual meeting
of the American Association for the Advancement of Science (AAAS).
She concluded that sunscreens may not actually protect against skin
cancers such as melanoma. In her own words: "We don't really
know whether sunscreens prevent skin cancer." Berwick first
looked at four studies of squamous cell cancer, a skin cancer that
is destructive but not frequently lethal. Two of the studies concluded
that sunscreen protected against a precancerous skin condition while
two others reported that sunscreen did not shield people from this
condition.
She then analyzed two studies of basal cell carcinoma, another
generally non-lethal skin cancer. Those two studies found that people
who used sunscreen were actually more likely to develop basal cell
cancer than people who did not.
Berwick then analyzed ten studies of melanoma, the most deadly
form of skin cancer. Melanoma often starts in or near moles on the
skin. In five of the ten melanoma studies, people who used sunscreen
were also more likely than nonusers to develop melanoma. In three
of the studies, there was no association between sunscreen use and
melanoma. In the final two studies, people who used sunscreen seemed
to be protected (Berwick 1998).
More recently, L.K. Dennis of the University of Iowa reviewed the
topic in the Annals of Internal Medicine. Again, he found that sunblocks
offered no protection "No association was seen between melanoma
and sunscreen use," he and his colleagues wrote (Dennis
2003).
Dr. Berwick's was a factual presentation. But the dermatology profession's
response to her analysis was as unmeasured as its response to Dr.
Holick. The American Academy of Dermatology promptly denounced the
Memorial Sloan-Kettering researcher's conclusions. In March 1998
the Academy issued a press release calling her message "misleading
and confusing."
Roger Ceilley, MD, a Des Moines dermatologist and a past president
of the Academy, called Berwick "a numbers cruncher," not
a doctor, according to an article in Science News. Incidentally,
Dr. Ceilley has only one PubMed article on the topic of melanoma,
dating from 1980 (Elmerts 1980). Dr. Berwick—the
Sloan-Kettering "numbers cruncher"—has 81 such publications.
"We're going to have millions more cases of skin cancer in
the next decade" if people forgo sunscreen, Dr. Ceilley proclaimed
(Fackelmann 1998).
TO BE CONTINUED, WITH REFERENCES, NEXT
WEEK
ACTION ALERT
The Dermatology Department at Boston University invites the public
to send comments, suggestions and concerns. Those wishing to comment
on the case of Dr. Holick should click or go to:
http://www.bumc.bu.edu/Departments/FeedbackMain.asp?DepartmentID=57&Script=%2FDepartments%2FPageMain%2Easp&Arguments=Page%3D5951%26DepartmentID%3D57
I would appreciate receiving a copy of any of your comments and
letters and with your permission may print some of them in a future
issue.
--Ralph W. Moss, Ph.D.

**NOTE**
To view this page in a more
printable format, please CLICK
HERE.
IMPORTANT DISCLAIMER
The news and other items in this newsletter
are intended for informational purposes only. Nothing in this newsletter
is intended to be a substitute for professional medical advice.
 |
|
CancerDecisions®
PO Box 1076, Lemont, PA 16851
Phone Toll Free: 800-980-1234 | Fax: 814-238-5865
Copyright
© 1996-2003 All Rights Reserved |
|
|